Login
Toggle navigation
Videos
Categories
Trending
Diversey IPO Preview with CEO Phil Wieland | Phil Wieland - CEO of Diversey Holdings
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Phil Wieland is the CEO of Diversey Holdings
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Trigon Metals Explores Copper Opportunities at One-to-One Conference
00:10:00
Oliver Hasler on PYX Resources’ Commitment to Sustainability and Global Zircon Leadership | Oliver Hasler, CEO , PYX Resources Ltd.
00:10:00
Balancing Act: Ayala Corporation's Financial Strategy Amidst Economic Dynamics and Sustainability Initiatives|CFO, Ayala Corp
00:10:00
Impact of Pandemic on Dividends, Outflows, and Work-from-Home Trends
00:10:00
Interview Summary: Empress Royalties with Alex W. Sharon
00:10:00
Exploring Rich Porphyry Copper-Gold Deposits in Ecuador: SolGold's Blueprint for Success
00:10:00
Engages founders working on the frontiers of science and technology|Deepak Gupta,Managing Partner,Blue Bear Ventures
00:10:00
Interview with Carlos Balestra: Mottola d'Amico International Shipping - VIRTUAL STAR CONFERENCE 2020 | Carlos Balestra di Mottola - Chief Executive Officer of d'Amico International Shipping S.A.
00:10:00
Transformative Growth: The Rise of Secondaries in Private Markets | Andres Small, Managing Director, Partners Group .
00:10:00
Billionaire Tom Steyer discusses a report release on CNBC, tied to Farallon Capital Management LLC.
00:10:00
Discover Modern Dollar: Your Fee-Only Financial Planning Partner
00:10:00
Curso de Impacto: Herramientas para Entender y Fortalecer Equipos